Affinis Hospice, Llc in Watkinsville, Georgia

Affinis Hospice, Llc is a medicare-certified hospice facility in Watkinsville, Georgia. It is a for profit hospice and this hospice is a Freestanding Hospice. It is located at 1612 Mars Hill Road, Suite A in Watkinsville, Georgia. You can reach out to the office of Affinis Hospice, Llc via phone at (706) 705-6000.

Affinis Hospice, Llc is first approved in February, 2014 to provide medicare and/or medicaid services and its CMS certification number (CCN) is 111743. Atlanta is the CMS Regional Office responsible for the certification of this hospice.

Contact Information


Affinis Hospice, Llc
1612 Mars Hill Road, Suite A, Watkinsville, GA, 30677
(706) 705-6000

News Archive

Study: Young Latinos in rural areas face discrimination when obtaining health care services

Young Latinos living in rural areas say they face discrimination when they obtain health care services - a factor that could contribute to disparities in their rates for obtaining medical care and in their health outcomes, a new study from Oregon State University has found.

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).

ADDF, AFTD announce recipients of Frontotemporal Dementia Drug Discovery Program award

The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.

Eight additional cases of MERS-CoV infection confirmed in Saudi Arabia

WHO has been informed of an additional eight laboratory-confirmed cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.

Novel way to dramatically raise potency of drug candidates targeting RNA

Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.

Read more Medical News

› Verified 3 days ago

Map and Direction



Hospice Profile

NameAffinis Hospice, Llc
Location1612 Mars Hill Road, Suite A, Watkinsville, Georgia
Hospice ID111743
CategoryFreestanding Hospice
Ownership TypeProprietary - Individual
Profit TypeFOR PROFIT
SSA county code800

News Archive

Study: Young Latinos in rural areas face discrimination when obtaining health care services

Young Latinos living in rural areas say they face discrimination when they obtain health care services - a factor that could contribute to disparities in their rates for obtaining medical care and in their health outcomes, a new study from Oregon State University has found.

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).

ADDF, AFTD announce recipients of Frontotemporal Dementia Drug Discovery Program award

The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.

Eight additional cases of MERS-CoV infection confirmed in Saudi Arabia

WHO has been informed of an additional eight laboratory-confirmed cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.

Novel way to dramatically raise potency of drug candidates targeting RNA

Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.

Read more Medical News

› Verified 3 days ago

NPI associated with this Hospice

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with Affinis Hospice, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1942634746
Organization NameAffinis Hospice, Llc
Address1612 Mars Hill Rd Watkinsville, Georgia, 30677
Phone Number(706)705-6000

News Archive

Study: Young Latinos in rural areas face discrimination when obtaining health care services

Young Latinos living in rural areas say they face discrimination when they obtain health care services - a factor that could contribute to disparities in their rates for obtaining medical care and in their health outcomes, a new study from Oregon State University has found.

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).

ADDF, AFTD announce recipients of Frontotemporal Dementia Drug Discovery Program award

The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.

Eight additional cases of MERS-CoV infection confirmed in Saudi Arabia

WHO has been informed of an additional eight laboratory-confirmed cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.

Novel way to dramatically raise potency of drug candidates targeting RNA

Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.

Read more Medical News

› Verified 3 days ago


Quality of Patient Care at Affinis Hospice, Llc

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. Affinis Hospice, Llc has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality MeasureProvider ScoreNational Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care96.098.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care84.093.6
Patients who were checked for pain at the beginning of hospice care84.093.9
Patients who got a timely and thorough pain assessment when pain was identified as a problemNot Available77.7
Patients who were checked for shortness of breath at the beginning of hospice care100.097.3
Patients who got timely treatment for shortness of breathNot Available94.6
Patients taking opioid pain medication who were offered care for constipationNot Available93.3

News Archive

Study: Young Latinos in rural areas face discrimination when obtaining health care services

Young Latinos living in rural areas say they face discrimination when they obtain health care services - a factor that could contribute to disparities in their rates for obtaining medical care and in their health outcomes, a new study from Oregon State University has found.

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).

ADDF, AFTD announce recipients of Frontotemporal Dementia Drug Discovery Program award

The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.

Eight additional cases of MERS-CoV infection confirmed in Saudi Arabia

WHO has been informed of an additional eight laboratory-confirmed cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.

Novel way to dramatically raise potency of drug candidates targeting RNA

Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.

Read more Medical News

› Verified 3 days ago


Services Provided by Affinis Hospice, Llc:

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by Affinis Hospice, Llc below:
  • By staff
    • Home Health Aide Service
    • Counseling Service
    • Medical Social Service
    • Nursing Service
    • Other Services

  • Under Arrangement
    • Medical Supply Service
    • Occupational Therapy
    • Physician Service
    • Physical Therapy
    • Short Term Inpatient care
    • Speech Pathology

  • Combination of Staff and Under Arrangement
    • No services

  • Type of Short Term Inpatient Care
    • Acute and Respite

Number of Full-time equivalent Employees:

Number of full time equivalent employees at Affinis Hospice, Llc
Home Health Aides3
Counselors1
Medical Social Workers 1
Physicians0.5
Registered Nurses2
Other Personnel1
Total Employees8.5

News Archive

Study: Young Latinos in rural areas face discrimination when obtaining health care services

Young Latinos living in rural areas say they face discrimination when they obtain health care services - a factor that could contribute to disparities in their rates for obtaining medical care and in their health outcomes, a new study from Oregon State University has found.

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).

ADDF, AFTD announce recipients of Frontotemporal Dementia Drug Discovery Program award

The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.

Eight additional cases of MERS-CoV infection confirmed in Saudi Arabia

WHO has been informed of an additional eight laboratory-confirmed cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.

Novel way to dramatically raise potency of drug candidates targeting RNA

Scientists from the Jupiter campus of The Scripps Research Institute (TSRI) have shown a novel way to dramatically raise the potency of drug candidates targeting RNA, resulting in a 2,500-fold improvement in potency and significantly increasing their potential as therapeutic agents.

Read more Medical News

› Verified 3 days ago

Certification Details for Affinis Hospice, Llc:

  • November, 2016 is the initial visit of the health survey for certifications by CMS.
  • It is in compliance at the time of certification survey by CMS.
  • It is in compliance with CMS program requirements based on an acceptable plan for correction of deficiencies.
  • It is eligible to participate in the medicare and/or medicaid program.
  • Blue Cross (south Carolina) is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
  • Current status is Active Provider.
  • Reason of certification is Recertification.
  • End of fiscal year is on 30, June.

Hospices in Watkinsville

Saint Mary's Hospice Services
Location: 1021 Jamestown Blvd Suite 215, Watkinsville, Georgia, 30677
Phone: (706) 705-6000
Pruitthealth Hospice-athens
Location: 1751 Meriweather Drive, Suite 1a, Watkinsville, Georgia, 30677
Phone: (706) 705-6000
Bridgeway Hospice
Location: 1731 Meriweather Drive Ste 101, Watkinsville, Georgia, 30677
Phone: (706) 705-6000
Affinis Hospice, Llc
Location: 1612 Mars Hill Road, Suite A, Watkinsville, Georgia, 30677
Phone: (706) 705-6000

Medicare Hospice Care

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.
  • A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
  • At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.